Insurance - Property & Casualty
Compare Stocks
5 / 10Stock Comparison
HCI vs UPC vs HRTG vs FG vs KINS
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
Insurance - Property & Casualty
Insurance - Life
Insurance - Property & Casualty
HCI vs UPC vs HRTG vs FG vs KINS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Property & Casualty | Drug Manufacturers - Specialty & Generic | Insurance - Property & Casualty | Insurance - Life | Insurance - Property & Casualty |
| Market Cap | $1.99B | $2M | $861M | $3.67B | $234M |
| Revenue (TTM) | $927M | $41M | $847M | $5.86B | $199M |
| Net Income (TTM) | $314M | $-12M | $196M | $530M | $41M |
| Gross Margin | 66.5% | 30.3% | 47.2% | 21.0% | 57.7% |
| Operating Margin | 47.9% | -26.7% | 31.7% | 6.0% | 25.6% |
| Forward P/E | 9.2x | — | 6.1x | 6.6x | 7.0x |
| Total Debt | $68M | $9M | $100M | $2.24B | $4M |
| Cash & Equiv. | $1.21B | $34M | $559M | $1.49B | $12M |
HCI vs UPC vs HRTG vs FG vs KINS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 22 | May 26 | Return |
|---|---|---|---|
| HCI Group, Inc. (HCI) | 100 | 408.5 | +308.5% |
| Universe Pharmaceut… (UPC) | 100 | 0.0 | -100.0% |
| Heritage Insurance … (HRTG) | 100 | 1698.8 | +1598.8% |
| F&G Annuities & Lif… (FG) | 100 | 117.8 | +17.8% |
| Kingstone Companies… (KINS) | 100 | 1600.0 | +1500.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCI vs UPC vs HRTG vs FG vs KINS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCI has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 20.2%, EPS growth 179.8%, 3Y rev CAGR 22.3%
- 436.8% 10Y total return vs HRTG's 119.4%
- Beta 0.39, yield 1.0%, current ratio 1.24x
- 33.9% margin vs UPC's -30.3%
Among these 5 stocks, UPC doesn't own a clear edge in any measured category.
HRTG is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Better valuation composite
- +15.3% vs UPC's -41.1%
FG is the clearest fit if your priority is income & stability.
- Dividend streak 4 yrs, beta 1.02, yield 3.8%
- 3.8% yield, 4-year raise streak, vs HCI's 1.0%, (2 stocks pay no dividend)
KINS ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.28, Low D/E 3.6%, current ratio 1.22x
- PEG 0.06 vs HRTG's 0.39
- 28.4% revenue growth vs UPC's -22.4%
- Beta 0.28 vs UPC's 1.26, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 28.4% revenue growth vs UPC's -22.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 33.9% margin vs UPC's -30.3% | |
| Stability / Safety | Beta 0.28 vs UPC's 1.26, lower leverage | |
| Dividends | 3.8% yield, 4-year raise streak, vs HCI's 1.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +15.3% vs UPC's -41.1% | |
| Efficiency (ROA) | 13.2% ROA vs UPC's -18.6%, ROIC 6.8% vs -7.8% |
HCI vs UPC vs HRTG vs FG vs KINS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HCI vs UPC vs HRTG vs FG vs KINS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCI leads in 1 of 6 categories
HRTG leads 1 • FG leads 1 • UPC leads 0 • KINS leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — HCI and FG each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FG is the larger business by revenue, generating $5.9B annually — 143.3x UPC's $41M. HCI is the more profitable business, keeping 33.9% of every revenue dollar as net income compared to UPC's -30.3%. On growth, FG holds the edge at +39.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $927M | $41M | $847M | $5.9B | $199M |
| EBITDAEarnings before interest/tax | $454M | -$10M | $281M | $1.4B | $54M |
| Net IncomeAfter-tax profit | $314M | -$12M | $196M | $530M | $41M |
| Free Cash FlowCash after capex | $431M | -$15M | $177M | $4.8B | $73M |
| Gross MarginGross profit ÷ Revenue | +66.5% | +30.3% | +47.2% | +21.0% | +57.7% |
| Operating MarginEBIT ÷ Revenue | +47.9% | -26.7% | +31.7% | +6.0% | +25.6% |
| Net MarginNet income ÷ Revenue | +33.9% | -30.3% | +23.1% | +9.0% | +20.5% |
| FCF MarginFCF ÷ Revenue | +46.4% | -37.2% | +20.8% | +82.3% | +36.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.9% | -14.1% | +2.4% | +39.0% | -3.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +23.4% | -100.1% | +2.3% | +9.9% | +157.5% |
Valuation Metrics
Evenly matched — UPC and HRTG each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 4.4x trailing earnings, HRTG trades at a 69% valuation discount to FG's 14.4x P/E. Adjusting for growth (PEG ratio), HRTG offers better value at 0.06x vs HCI's 0.13x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.0B | $2M | $861M | $3.7B | $234M |
| Enterprise ValueMkt cap + debt − cash | $844M | -$23M | $402M | $4.4B | $226M |
| Trailing P/EPrice ÷ TTM EPS | 6.15x | -0.00x | 4.44x | 14.41x | 5.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.19x | — | 6.07x | 6.60x | 7.03x |
| PEG RatioP/E ÷ EPS growth rate | 0.13x | — | 0.06x | — | 0.06x |
| EV / EBITDAEnterprise value multiple | 1.92x | — | 1.48x | 4.48x | 4.22x |
| Price / SalesMarket cap ÷ Revenue | 2.20x | 0.09x | 1.02x | 0.64x | 1.17x |
| Price / BookPrice ÷ Book value/share | 1.77x | 0.00x | 1.72x | 0.73x | 1.86x |
| Price / FCFMarket cap ÷ FCF | 4.47x | — | 4.94x | 0.79x | 3.20x |
Profitability & Efficiency
HCI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
HRTG delivers a 47.3% return on equity — every $100 of shareholder capital generates $47 in annual profit, vs $-27 for UPC. KINS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to FG's 0.45x. On the Piotroski fundamental quality scale (0–9), HCI scores 8/9 vs UPC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +32.0% | -27.0% | +47.3% | +11.1% | +40.0% |
| ROA (TTM)Return on assets | +13.2% | -18.6% | +8.4% | +0.5% | +9.8% |
| ROICReturn on invested capital | +6.8% | -7.8% | +15.4% | +5.0% | +46.6% |
| ROCEReturn on capital employed | +40.6% | -5.6% | +11.1% | +0.4% | +20.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 4 | 7 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.06x | 0.16x | 0.20x | 0.45x | 0.04x |
| Net DebtTotal debt minus cash | -$1.1B | -$24M | -$459M | $751M | -$8M |
| Cash & Equiv.Liquid assets | $1.2B | $34M | $559M | $1.5B | $12M |
| Total DebtShort + long-term debt | $68M | $9M | $100M | $2.2B | $4M |
| Interest CoverageEBIT ÷ Interest expense | 67.24x | -22.11x | 33.88x | 2.87x | 115.65x |
Total Returns (Dividends Reinvested)
HRTG leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HRTG five years ago would be worth $30,138 today (with dividends reinvested), compared to $3 for UPC. Over the past 12 months, HRTG leads with a +15.3% total return vs UPC's -41.1%. The 3-year compound annual growth rate (CAGR) favors KINS at 127.2% vs UPC's -89.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.7% | -27.9% | +2.7% | -9.0% | -0.3% |
| 1-Year ReturnPast 12 months | +2.4% | -41.1% | +15.3% | -22.0% | -10.1% |
| 3-Year ReturnCumulative with dividends | +209.6% | -99.9% | +585.3% | +77.6% | +1073.4% |
| 5-Year ReturnCumulative with dividends | +105.3% | -100.0% | +201.4% | +78.6% | +99.4% |
| 10-Year ReturnCumulative with dividends | +436.8% | -100.0% | +119.4% | +78.6% | +101.9% |
| CAGR (3Y)Annualised 3-year return | +45.7% | -89.3% | +89.9% | +21.1% | +127.2% |
Risk & Volatility
Evenly matched — HRTG and KINS each lead in 1 of 2 comparable metrics.
Risk & Volatility
KINS is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than UPC's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HRTG currently trades 87.6% from its 52-week high vs UPC's 27.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.39x | 1.26x | 0.50x | 1.02x | 0.28x |
| 52-Week HighHighest price in past year | $210.50 | $11.00 | $31.98 | $36.70 | $22.40 |
| 52-Week LowLowest price in past year | $136.37 | $2.00 | $16.83 | $20.57 | $13.08 |
| % of 52W HighCurrent price vs 52-week peak | +72.6% | +27.3% | +87.6% | +73.8% | +72.1% |
| RSI (14)Momentum oscillator 0–100 | 48.7 | 41.9 | 55.7 | 71.6 | 50.5 |
| Avg Volume (50D)Average daily shares traded | 167K | 8K | 282K | 591K | 113K |
Analyst Outlook
FG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HCI as "Buy", HRTG as "Buy", FG as "Hold", KINS as "Buy". Consensus price targets imply 39.1% upside for HRTG (target: $39) vs -17.2% for HCI (target: $127). For income investors, FG offers the higher dividend yield at 3.83% vs KINS's 0.62%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $126.50 | — | $39.00 | $31.00 | — |
| # AnalystsCovering analysts | 14 | — | 9 | 9 | 4 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | — | — | +3.8% | +0.6% |
| Dividend StreakConsecutive years of raises | 2 | 2 | 1 | 4 | 0 |
| Dividend / ShareAnnual DPS | $1.50 | — | — | $1.04 | $0.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +0.3% | +0.3% | 0.0% |
HCI leads in 1 of 6 categories (Profitability & Efficiency). HRTG leads in 1 (Total Returns). 3 tied.
HCI vs UPC vs HRTG vs FG vs KINS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HCI or UPC or HRTG or FG or KINS a better buy right now?
For growth investors, Kingstone Companies, Inc.
(KINS) is the stronger pick with 28. 4% revenue growth year-over-year, versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). Heritage Insurance Holdings, Inc. (HRTG) offers the better valuation at 4. 4x trailing P/E (6. 1x forward), making it the more compelling value choice. Analysts rate HCI Group, Inc. (HCI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCI or UPC or HRTG or FG or KINS?
On trailing P/E, Heritage Insurance Holdings, Inc.
(HRTG) is the cheapest at 4. 4x versus F&G Annuities & Life, Inc. at 14. 4x. On forward P/E, Heritage Insurance Holdings, Inc. is actually cheaper at 6. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: HCI Group, Inc. wins at 0. 19x versus Heritage Insurance Holdings, Inc. 's 0. 39x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — HCI or UPC or HRTG or FG or KINS?
Over the past 5 years, Heritage Insurance Holdings, Inc.
(HRTG) delivered a total return of +201. 4%, compared to -100. 0% for Universe Pharmaceuticals Inc. (UPC). Over 10 years, the gap is even starker: HCI returned +436. 8% versus UPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCI or UPC or HRTG or FG or KINS?
By beta (market sensitivity over 5 years), Kingstone Companies, Inc.
(KINS) is the lower-risk stock at 0. 28β versus Universe Pharmaceuticals Inc. 's 1. 26β — meaning UPC is approximately 358% more volatile than KINS relative to the S&P 500. On balance sheet safety, Kingstone Companies, Inc. (KINS) carries a lower debt/equity ratio of 4% versus 45% for F&G Annuities & Life, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HCI or UPC or HRTG or FG or KINS?
By revenue growth (latest reported year), Kingstone Companies, Inc.
(KINS) is pulling ahead at 28. 4% versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). On earnings-per-share growth, the picture is similar: Heritage Insurance Holdings, Inc. grew EPS 214. 4% year-over-year, compared to -61. 5% for F&G Annuities & Life, Inc.. Over a 3-year CAGR, FG leads at 36. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCI or UPC or HRTG or FG or KINS?
HCI Group, Inc.
(HCI) is the more profitable company, earning 33. 2% net margin versus -20. 6% for Universe Pharmaceuticals Inc. — meaning it keeps 33. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCI leads at 47. 7% versus -16. 3% for UPC. At the gross margin level — before operating expenses — HCI leads at 73. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCI or UPC or HRTG or FG or KINS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, HCI Group, Inc. (HCI) is the more undervalued stock at a PEG of 0. 19x versus Heritage Insurance Holdings, Inc. 's 0. 39x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Heritage Insurance Holdings, Inc. (HRTG) trades at 6. 1x forward P/E versus 9. 2x for HCI Group, Inc. — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HRTG: 39. 1% to $39. 00.
08Which pays a better dividend — HCI or UPC or HRTG or FG or KINS?
In this comparison, FG (3.
8% yield), HCI (1. 0% yield), KINS (0. 6% yield) pay a dividend. UPC, HRTG do not pay a meaningful dividend and should not be held primarily for income.
09Is HCI or UPC or HRTG or FG or KINS better for a retirement portfolio?
For long-horizon retirement investors, HCI Group, Inc.
(HCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 39), 1. 0% yield, +436. 8% 10Y return). Both have compounded well over 10 years (HCI: +436. 8%, UPC: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCI and UPC and HRTG and FG and KINS?
These companies operate in different sectors (HCI (Financial Services) and UPC (Healthcare) and HRTG (Financial Services) and FG (Financial Services) and KINS (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCI is a small-cap high-growth stock; UPC is a small-cap quality compounder stock; HRTG is a small-cap deep-value stock; FG is a small-cap deep-value stock; KINS is a small-cap high-growth stock. HCI, FG, KINS pay a dividend while UPC, HRTG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.